18F-FDG PET/CT for monitoring induction chemotherapy in patients with primary inoperable penile carcinoma: First clinical results

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 37, Issue 8, 2010, Pages 1474-1480

  Graafland, Niels M ^a   Valdés Olmos, Renato A ^a   Teertstra, Hendrik J ^a   Kerst, J Martijn ^a   Bergman, Andries M ^a   Horenblas, Simon ^a  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

Induction chemotherapy; Monitoring treatment response; Neoadjuvant; Neoplasm staging; Penile carcinoma; PET CT

Indexed keywords

BLEOMYCIN; CISPLATIN; DOCETAXEL; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; IRINOTECAN; METHOTREXATE; DIAGNOSTIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MULTIPLE CYCLE TREATMENT; PENIS CARCINOMA; POSITRON EMISSION TOMOGRAPHY; TREATMENT RESPONSE; MALE; METABOLISM; MIDDLE AGED; PENIS TUMOR; TREATMENT OUTCOME;

AGED; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; PENILE NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 77956185787     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-010-1434-0     Document Type: Article

References (23)

1. E Solsona F Algaba S Horenblas G Pizzocaro T Windahl European Association of Urology 2004 EAU Guidelines on Penile Cancer Eur Urol 46 1 8 10.1016/j.eururo.2004.03.007 1:STN:280:DC%2BD2c3otlGjsw%3D%3D 15183542
2. DJ Culkin TM Beer 2003 Advanced penile carcinoma J Urol 170 359 365 10.1097/01.ju.0000062829.43654.5e 12853775
3. JA Leijte JM Kerst E Bais N Antonini S Horenblas 2007 Neoadjuvant chemotherapy in advanced penile carcinoma Eur Urol 52 488 494 10.1016/j.eururo.2007.02.006 1:CAS:528:DC%2BD2sXpsFKltbc%3D 17316964
4. G Pizzocaro N Nicolai A Milani 2009 Taxanes in combination with cisplatin and fluorouracil for advanced penile cancer: preliminary results Eur Urol 55 546 551 10.1016/j.eururo.2008.07.014 1:CAS:528:DC%2BD1MXns1Cksrw%3D 18649992
5. ME Juweid BD Cheson 2006 Positron-emission tomography and assessment of cancer therapy N Engl J Med 354 496 507 10.1056/NEJMra050276 1:CAS:528:DC%2BD28Xptlajsw%3D%3D 16452561
6. JW Fletcher B Djulbegovic HP Soares BA Siegel VJ Lowe GH Lyman, et al. 2008 Recommendations on the use of 18F-FDG PET in oncology J Nucl Med 49 480 508 10.2967/jnumed.107.047787 18287273
7. M Schelling N Avril J Nährig W Kuhn W Römer D Sattler, et al. 2000 Positron emission tomography using [(18)F]fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer J Clin Oncol 18 1689 1695 1:STN:280:DC%2BD3c3islyjsw%3D%3D 10764429
8. N Avril S Sassen B Schmalfeldt J Naehrig S Rutke WA Weber, et al. 2005 Prediction of response to neoadjuvant chemotherapy by sequential F-18-fluorodeoxyglucose positron emission tomography in patients with advanced-stage ovarian cancer J Clin Oncol 23 7445 7453 10.1200/JCO.2005.06.965 16157939
9. K Ott WA Weber F Lordick K Becker R Busch K Herrmann, et al. 2006 Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction J Clin Oncol 24 4692 4698 10.1200/JCO.2006.06. 7801 16966684
10. J Schwarz-Dose M Untch R Tiling S Sassen S Mahner S Kahlert, et al. 2009 Monitoring primary systemic therapy of large and locally advanced breast cancer by using sequential positron emission tomography imaging with [18F]fluorodeoxyglucose J Clin Oncol 27 535 541 10.1200/JCO.2008.17.2650 19075273
11. T Powles I Murray C Brock T Oliver N Avril 2007 Molecular positron emission tomography and PET/CT imaging in urological malignancies Eur Urol 51 1511 1520 10.1016/j.eururo.2007.01.061 17275167
12. G Antoch N Saoudi H Kuehl G Dahmen SP Mueller T Beyer, et al. 2004 Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET J Clin Oncol 22 4357 4368 10.1200/JCO.2004.08.120 15514377
13. J Czernin M Allen-Auerbach HR Schelbert 2007 Improvements in cancer staging with PET/CT: literature-based evidence as of September 2006 J Nucl Med 48 Suppl 1 78S 88S 1:CAS:528:DC%2BD2sXitVamsrw%3D 17204723
14. B Scher M Seitz M Reiser E Hungerhuber K Hahn R Tiling, et al. 2005 18F-FDG PET/CT for staging of penile cancer J Nucl Med 46 1460 1465 16157528
15. NM Graafland JA Leijte RA Valdés Olmos CA Hoefnagel HJ Teertstra S Horenblas 2009 Scanning with 18F-FDG-PET/CT for detection of pelvic nodal involvement in inguinal node-positive penile carcinoma Eur Urol 56 339 345 10.1016/j.eururo.2009.05.016 19477581
16. Sobin L, Wittekind Ch. TNM classification of malignant tumours. 6th ed. New York: Wiley-Liss; 2002.
17. H Young R Baum U Cremerius K Herholz O Hoekstra AA Lammertsma, et al. 1999 Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group Eur J Cancer 35 1773 1782 10.1016/S0959-8049(99)00229-4 1:STN:280:DC%2BD3c7jvV2ntA%3D%3D 10673991
18. P Therasse SG Arbuck EA Eisenhauer J Wanders RS Kaplan L Rubinstein, et al. 2000 New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 92 205 216 10.1093/jnci/92.3.205 1:STN:280:DC%2BD3c7it1Gitg%3D%3D 10655437
19. JE Husband LH Schwartz J Spencer L Ollivier DM King R Johnson, et al. 2004 Evaluation of the response to treatment of solid tumours-a consensus statement of the International Cancer Imaging Society Br J Cancer 90 2256 2260 1:STN:280:DC%2BD2c3os1eksw%3D%3D 15150551
20. Y Zhu SL Zhang DW Ye XD Yao ZX Jiang XY Zhou 2008 Predicting pelvic lymph node metastases in penile cancer patients: a comparison of computed tomography, Cloquet's node, and disease burden of inguinal lymph nodes Onkologie 31 37 41 10.1159/000112462 1:CAS:528:DC%2BD1MXltVSgtbw%3D 18268397
21. AP Lont BK Kroon MP Gallee H van Tinteren LM Moonen S Horenblas 2007 Pelvic lymph node dissection for penile carcinoma: extent of inguinal lymph node involvement as an indicator for pelvic lymph node involvement and survival J Urol 177 947 952 10.1016/j.juro.2006.10.060 17296384
22. D Pandey V Mahajan RR Kannan 2006 Prognostic factors in node-positive carcinoma of the penis J Surg Oncol 93 133 138 10.1002/jso.20414 16425300
23. F Lordick K Ott BJ Krause WA Weber K Becker HJ Stein, et al. 2007 PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial Lancet Oncol 8 797 805 10.1016/S1470-2045(07)70244-9 17693134